Speaker Profile
Ph.D., Founder, Kleiner Perkins
Biography
Brook Byers has been a venture capital investor since 1972. He has been closely involved with founders to help build more than 60 new science-based companies. He formed the first life sciences practice group in the venture capital profession in 1984 and led Kleiner Perkins to become a premier venture capital firm in the life sciences, healthcare and biotechnology sectors.Brook was the founding president and then chairman of four biotechnology companies that were incubated in Kleiner Perkins offices and went on to become public companies with an aggregate market value of more than US$8 billion. He currently serves on the board of directors of Arsenal Bio, Octave Bio, Newsela and Verana Health. Brook is a Lifetime Board Member of the University of California San Francisco Medical Center. He served on the Board of Trustees of Stanford University and the Georgia Tech Advisory Board. He received an Honorary PhD from Georgia Tech.
Session Abstract – PMWC 2026 Silicon Valley
Track Chair: TBA
PMWC Award Ceremony Honorees
• Mark Daly, Broad Institute
• Daniel MacArthur, CPG/Genomes/gnomAD
• Gordon Sanghera, Oxford Nanopore
• Howard J. Jacob, Abbvie
The Data Factory: Building Systems to Integrate Millions of Genomes for Variant Interpretation
• Chair: Stephen B. Montgomery, Stanford
• Carlos D. Bustamante, University of Oklahoma
• Mark Daly, Broad Institute/FinnGen
• Manuel Rivas, Stanford
• Mark McCarthy, Genentech
• Nilah Ioannidis, UC Berkeley
Biobanks to Bedside: Cutting VUS in Cancer, Cardio & Rare—What’s Working Now
• Chair: Ben Neale, Broad Institute
• Daniel MacArthur, CPG/Genomes/gnomAD
Beyond the Read: Integrating Long-Read Data into the Clinical Variant Pipeline
• Chair: Gordon Sanghera, Oxford Nanopore Technologies
• Hanlee P. Ji, Stanford
DNA to FDA: How Genetic Targets Win Labels & Coverage
• Russ B. Altman, Stanford
Common Diseases in Clinical Cohorts – Not Always What They Seem
• Howard J. Jacob, Abbvie
DNA to FDA: How Genetic Targets Win Labels & Coverage
• Chair: Razelle Kurzrock, Medical College of Wisconsin
• Russ B. Altman, Stanford
25+ Years of the Human Genome — What Made It to the Bedside
• Chair: Ralph Snyderman, Duke
• J. Craig Venter, Craig Venter Institute (JCVI)
• Brook Byers, KPCB
• Lee Hood, Phenome Health
